Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,494 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Potential Involvement of Extracellular Citrate in Brain Tumor Progression.
Jordan K, Stanton EH, Milenkovic VM, Federlin M, Drexler K, Buchalla W, Gaumann A, Adamski J, Proescholdt M, Haferkamp S, Geissler EK, Mycielska ME. Jordan K, et al. Curr Mol Med. 2022;22(6):506-513. doi: 10.2174/1566524021666210302143802. Curr Mol Med. 2022. PMID: 33653247 Review.
Cancer-associated cells release citrate to support tumour metastatic progression.
Drexler K, Schmidt KM, Jordan K, Federlin M, Milenkovic VM, Liebisch G, Artati A, Schmidl C, Madej G, Tokarz J, Cecil A, Jagla W, Haerteis S, Aung T, Wagner C, Kolodziejczyk M, Heinke S, Stanton EH, Schwertner B, Riegel D, Wetzel CH, Buchalla W, Proescholdt M, Klein CA, Berneburg M, Schlitt HJ, Brabletz T, Ziegler C, Parkinson EK, Gaumann A, Geissler EK, Adamski J, Haferkamp S, Mycielska ME. Drexler K, et al. Among authors: jordan k. Life Sci Alliance. 2021 Mar 23;4(6):e202000903. doi: 10.26508/lsa.202000903. Print 2021 Jun. Life Sci Alliance. 2021. PMID: 33758075 Free PMC article.
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation.
Nguyen LL, Watson ZL, Ortega R, Woodruff ER, Jordan KR, Iwanaga R, Yamamoto TM, Bailey CA, To F, Jeong AD, Guntupalli SR, Behbakht K, Gibaja V, Arnoult N, Cocozaki A, Chuong EB, Bitler BG. Nguyen LL, et al. Among authors: jordan kr. Mol Cancer Ther. 2024 May 8. doi: 10.1158/1535-7163.MCT-23-0613. Online ahead of print. Mol Cancer Ther. 2024. PMID: 38714351
Academic performance of students in an accelerated medical pathway.
Chen F, Jordan KA, Li W, Lam Y, Pascarella L, Coe CL. Chen F, et al. Among authors: jordan ka. Med Educ Online. 2024 Dec 31;29(1):2345444. doi: 10.1080/10872981.2024.2345444. Epub 2024 Apr 28. Med Educ Online. 2024. PMID: 38678447 Free PMC article.
A Phase Ib Expansion Cohort Evaluating Aurora A Kinase Inhibitor Alisertib and Dual TORC1/2 Inhibitor Sapanisertib in Patients with Advanced Solid Tumors.
Davis SL, Messersmith WA, Purcell WT, Lam ET, Corr BR, Leal AD, Lieu CH, O'Bryant CL, Smoots SG, Dus ED, Jordan KR, Serkova NJ, Pitts TM, Diamond JR. Davis SL, et al. Among authors: jordan kr. Cancers (Basel). 2024 Apr 10;16(8):1456. doi: 10.3390/cancers16081456. Cancers (Basel). 2024. PMID: 38672538 Free PMC article.
Using Virtual Reality to Study Spatial Mapping and Threat Learning.
Marino CE, Rjabtsenkov P, Sharp C, Ali Z, Pineda E, Bavdekar S, Garg T, Jordan K, Halvorsen M, Aponte C, Blue J, Zhu X, Jimenez BS. Marino CE, et al. Among authors: jordan k. Res Sq [Preprint]. 2024 Apr 3:rs.3.rs-3891586. doi: 10.21203/rs.3.rs-3891586/v1. Res Sq. 2024. PMID: 38645017 Free PMC article. Preprint.
1,494 results